Home Tags NYSE:INCY

Tag: NYSE:INCY

Don’t Let Stock Prices Fool You: Incyte Corporation (INCY), Commercial Metals...

Incyte Corporation (NASDAQ:INCY) has a price-to-sales ratio of 8.5, well below its Biotechnology competitors. For the industry, the average P/S ratio sits at 107.32,...

An Eye On Valuation Metrics Of Incyte Corporation (INCY), Jefferies Financial...

Incyte Corporation (NASDAQ:INCY) is expensive when one looks at the company's price to sales ratio of 8.89 and compares it with other companies in...

A Valuation Showdown? – Incyte Corporation (INCY), Wheaton Precious Metals Corp....

Incyte Corporation (NASDAQ:INCY) is offering a substantial bargain with a P/S ratio at 8.46. The broad Biotechnology industry has an average P/S ratio of...

Where Does These Stocks Go From Here? – Incyte Corporation (INCY),...

Investors making a wish list of stocks to watch should take a look at Incyte Corporation (NASDAQ:INCY). The stock is offering a price-to-sales ratio...

Experiencing The Start Of A New Trend? – Incyte Corporation (INCY),...

Incyte Corporation (NASDAQ:INCY)'s price-to-sales ratio of 9.47 is creating a long-term opportunity in the value in its stock. The broad Biotechnology industry has an...

2 Value Stocks to Dive Into Now: Incyte Corporation (INCY), Companhia...

Incyte Corporation (NASDAQ:INCY) is simply too cheap to pass with a price-to-sales ratio of 9.7. The competitors from Biotechnology hold an average P/S ratio...